Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
- PMID: 8705859
- DOI: 10.1038/nm0896-893
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Abstract
Tuberculosis is the most widespread and lethal infectious disease affecting humans. Immunization of mice with plasmid DNA constructs encoding one of the secreted components of Mycobacterium tuberculosis, antigen 85 (Ag85), induced substantial humoral and cell-mediated immune responses and conferred significant protection against challenge with live M. tuberculosis and M. bovis bacille Calmette-Guérin (BCG). These results indicate that immunization with DNA encoding a mycobacterial antigen provides an efficient and simple method for generating protective immunity and that this technique may be useful for defining the protective antigens of M. tuberculosis, leading to the development of a more effective vaccine.
Comment in
-
Genetic vaccination: the advantages of going naked.Nat Med. 1996 Aug;2(8):857-9. doi: 10.1038/nm0896-857. Nat Med. 1996. PMID: 8705850 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical